Literature DB >> 11737990

High performance liquid chromatography of mebudipine: application to pharmacokinetic study.

S Bohlooli1, F Keyhanfar, M Mahmoudian.   

Abstract

PURPOSE: To develop a high performance liquid chromatography system for the determination of a new 1,4-dihydropyridine, mebudipine, in rabbit plasma.
METHODS: To 1 ml of rabbit plasma was added internal standard (dibudipine) and 0.5 ml of 1 M NaOH. Mebudipine and internal standard were extracted to 5 ml ethyl acetate, evaporated under slow stream of nitrogen. The residue was reconstituted in 200 microl mobile phase and 20 microl of aliquots were injected into a HPLC system equipped with 4.6 x 250 mm i.d. C18 analytical column. Mobile phase consisted of methanol (70%), water (25%) and acetonitril (5%) and its flow rate was 1 ml/min.
RESULTS: There were no interfering peaks from endogenous components in blank plasma chromatograms. Standard curves were linear (r(2)>0.99) over 10 to 500 ng/ml. The extraction efficiency was >90% and the minimum quantifiable concentration was 10 ng/ml (CV<10%).
CONCLUSION: A suitable, convenient and simple HPLC assay for pharmacokinetic study of mebudipine in rabbits was developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737990

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  2 in total

1.  Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

Authors:  Samira Khani; Fariborz Keyhanfar
Journal:  AAPS PharmSciTech       Date:  2013-10-23       Impact factor: 3.246

2.  Determination of Mebudipine in Human Plasma by Liquid Chromatography-tandem Mass Spectrometry.

Authors:  Arezoo Asgari; Farzad Kobarfard; Fariborz Keyhanfar; Shohreh Mohebbi; Maryam Noubarani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.